Lucas T. Laudermilk

发表

MicroRNAs Form Triplexes with Double Stranded DNA at Sequence-Specific Binding Sites; a Eukaryotic Mechanism via which microRNAs Could Directly Alter Gene Expression

Edward C. Uberbacher, Philip F. LoCascio, Mark R. Wilkinson, 2016, PLoS Comput. Biol..

NALP3 inflammasome up-regulation and CASP1 cleavage of the glucocorticoid receptor causes glucocorticoid resistance in leukemia cells

Lucas T. Laudermilk, Thomas L. Dunwell, R. Myers, 2015, Nature Genetics.

Evaluation of Amide Bioisosteres Leading to 1,2,3-Triazole Containing Compounds as GPR88 Agonists: Design, Synthesis, and Structure-Activity Relationship Studies.

Lucas T. Laudermilk, B. Kieffer, E. Darcq, 2021, Journal of medicinal chemistry.

Behavioral assessment of rimonabant under acute and chronic conditions

Lucas T. Laudermilk, S. Clark, R. Maitra, 2020, Behavioural Brain Research.

Structure–Activity Relationship Development Efforts towards Peripherally Selective Analogs of the Cannabinoid Receptor Partial Agonist BAY 59-3074

Lucas T. Laudermilk, R. Maitra, D. Harris, 2022, Molecules.

Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice.

Lucas T. Laudermilk, Nayaab S. Khan, T. Rosa, 2021, ACS pharmacology & translational science.

Design, Synthesis, and Structure-Activity Relationship Studies of (4-Alkoxyphenyl)glycinamides and Bioisosteric 1,3,4-Oxadiazoles as GPR88 Agonists.

Lucas T. Laudermilk, B. Kieffer, E. Darcq, 2020, Journal of medicinal chemistry.

Differential Regulation of Zfp30 Expression in Murine Airway Epithelia Through Altered Binding of ZFP148 to rs51434084

Lucas T. Laudermilk, S. Kelada, Joseph M. Thomas, 2017, G3: Genes, Genomes, Genetics.

Aplnr knockout mice display sex-specific changes in conditioned fear

Lucas T. Laudermilk, Bin Zhou, B. Koller, 2020, Behavioural Brain Research.

Baseline and innate immune response characterization of a Zfp30 knockout mouse strain

Lucas T. Laudermilk, D. Cowley, J. Mock, 2020, Mammalian Genome.

Novel Peripherally Selective Cannabinoid Receptor 1 Neutral Antagonist Improves Metabolic Dysfunction-Associated Steatotic Liver Disease in Mice.

Lucas T. Laudermilk, J. Schlosburg, Vineetha Vasukuttan, 2024, ACS pharmacology & translational science.